Reference
National Pharmaceutical Regulatory Agency (NPRA), Malaysia. Eylea(R) vs. Zaltrap(R) (aflibercept): Same Active Ingredient, Different Safety Profiles? Reaksi Drug Safety News : 1-2, No. 33, Jan 2017. Available from: URL: http://npra.moh.gov.my
Rights and permissions
About this article
Cite this article
Malaysia's NPRA compares safety of two aflibercept products. Reactions Weekly 1640, 1 (2017). https://doi.org/10.1007/s40278-017-26554-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-26554-9